CHEMICAL CONSULTANTS NETWORK

Peter Mlynek

Law Offices of Peter D. Mlynek, LLC

 

Member profile details

First name
Peter
Last name
Mlynek
Organization
Law Offices of Peter D. Mlynek, LLC
 

Contact information

City
Moorestown
State or Province
New Jersey
Zip Code
08057
Country
United States
Phone
6098417805
Phone (Alternate)
609-841-7805
 

Specialties and Services

Fields of Expertise
  • Attorney
  • Patents
Summary
I am a patent attorney specializing in chemical, chemical engineering, pharmaceutical, or biotechnology business sectors.
Services
• Business Counseling: planning, developing and executing patenting strategy that fits the clients’ business goals.
• Obtaining US patents: drafting and prosecuting patent applications to clients’ inventions.
• Obtaining patents outside of the US: we work through non-US law firms to obtain patents in selected countries.
• Providing Patent Opinions: freedom to operate opinions, patent invalidity opinions, infringement opinions, and due diligence analysis associated with M&A transactions.
• Licensing of intellectual property.
• Protecting business intellectual property by securing patents, trademarks, copyrights, and trade secrets.

We view issued patents, legal opinions, licenses agreements, and other documents in the realm of intellectual property not simply as enforceable legal documents, or disclosures of scientific prowess, but primarily as business tools necessary to achieve business goals. We work with business owners, managers and leaders to obtain the appropriate level of patent protection.
More Services
PATENT PROCUREMENT

For larger clients, we work with in-house counsels looking for better, faster and cheaper solutions to their patent procurement problems. For medium sized businesses, we provide intellectual property services that resemble in-house counsel work of patent attorneys without incurring the overhead costs. For small business owners and individual inventor, we provide business advice on obtaining and leveraging intellectual property.


INTELLECTUAL PROPERTY DUE DILIGENCE

For clients interested in acquiring new businesses through M&A, or venturing into new technological areas, we provide intellectual property due diligence services. These may include FTO opinions, patent invalidity opinions, infringement opinions, exclusivity opinion, ownership analysis, and like.
 

Additional Information

Additional Info
Although we are not limited by industries that we serve, we generally focus on serving the needs of clients in industries where chemical, biotech or pharmaceutical technologies play an important role. These include the following industries.


Agrochemicals
Animal Health
Biotechnology
Catalysts
Ceramics & Glass
Chemicals
Cosmetics
Dermatologicals
Films & Coatings
Food & Beverage
Fragrances & Flavors
Healthcare & Medical
Household products
Inks
Inorganic Industrials
In Vivo Diagnostic
Pharmaceuticals
Personal Care
Oil & Gas
Petrochemicals
Polymers
Rubber
Sealants & Adhesives
Specialty Chemicals
Surfactants
Water Treatment
More Additional Info
SMALL COMPANIES AND INDIVIDUAL INVENTORS

We work with individual inventors and small businesses. For such clients we have been successful in obtaining cutting-edge U.S. and non-U.S. patents at reasonable costs, and providing strategic consulting that contributes to the bottom line.

For small companies and individual inventors in technologically driven industries, the number one concern repeatedly expressed when it comes to patent protection is its high cost. The costs of obtaining patents, and the costs of enforcing such patents are very high when compared to the size of the business. We sympathize. Unlike most capital investments and operational outlays that companies undertake, unfortunately, there simply are no economies of scale when it comes to procuring or enforcing patent protection. The amount of time and effort to get a patent for a small company is the same as for a large company. There are no corners to cut on the scope or quality of a patent, because clever competitors will design around patents that are too narrow and will ignore patents of questionable quality. Further, patents of limited scope or of questionable quality will not count for much when M&A suitors are looking to acquire an interest in the company. We have several years of experience of working on behalf of large companies performing due diligence on intellectual property estates of small companies, so we understand what potential suitors may be looking for.

To address the concern of high cost, we have developed strategies applicable to small businesses and individual inventors. Firstly, we simply charge a lot less than large general practice law firms or patent boutiques. Second, we offer flat fee pay structure, so that the small business can easily budget for the cost of patent procurement. Thirdly, we work closely with the client to not simply provide a patent, but to analyze the business needs of the client to make sure if a patent is even needed.

Beyond patent procurement, services offered to small businesses and individual inventors include strategic consulting on how to leverage patents to advance the business goals of the clients. Peter’s background is not only in law and science, but also in business: MBA from one of the top business school and in-house experience as a scientist and a patent liaison.

We look forward to speaking with you at your earliest convenience to discuss how we may help your business prosper. Please contact us at +1-856-787-0880 or at info@mlyneklaw.com.
Experience
LEGAL EXPERIENCE

Prior to launching his own firm, Peter was a member of the Philadelphia office of a large East Coast general practice law firm, where he prepared opinions and performed due diligence analyses of acquisition targets in small molecules and biopharma businesses for a major pharmaceutical client. He also prepared and prosecuted U.S. patent applications, and directed prosecution of international patent applications. Further, he aided with pharmaceutical litigation by drafting pleadings on behalf of a large pharmaceutical company.

Peter also spend 6 years at a medium-sized intellectual property boutique as a patent agent and later as an associate, where he prepared, and prosecuted U.S. patent applications and directed prosecution of international patent applications; prosecuted and supervised international prosecution of a 240-application global patent portfolio for iloperidone (now Fanapt®); advised business decision-makers in Fortune 500 companies on global patent portfolio strategies; prepared reports on patent landscape prior to client’s entry into new business markets; was the working attorney on a winning patent interference case; and supported trademark opposition proceedings, and patent litigation. Peter also spend 6 years at a medium-sized intellectual property boutique as a patent agent and later as an associate, where he prepared, and prosecuted U.S. patent applications and directed prosecution of international patent applications; prosecuted and supervised international prosecution of a 240-application global patent portfolio for iloperidone (now Fanapt®); advised business decision-makers in Fortune 500 companies on global patent portfolio strategies; prepared reports on patent landscape prior to client’s entry into new business markets; was the working attorney on a winning patent interference case; and supported trademark opposition proceedings, and patent litigation.
More Experience
INDUSTRIAL EXPERIENCE

Peter worked for over five years as a Senior Technical Specialist and a Patent Liaison for ICI Polyurethanes and Huntsman Polyurethanes. As a Patent Liaison he interacted with patent counsel and inventors; performed patent portfolio/business strategy formulation; and provided legal opinion and due diligence support. As a product development professional in polymer chemistry, his work included experimental design, directing screening and optimization of polymer formulation, developing new methods, and advising on business strategy.
Education
EDUCATION: B.S. UC-Berkeley, Ph.D. UW-Madison, MBA UW-Madison, JD Rutgers


J.D.: Rutgers University School of Law– Camden.

Ph.D. - Chemistry: University of Wisconsin–Madison. The research work on resulted in 4 academic papers and several posters. He also taught undergraduate chemistry for which he was awarded Citation for Teaching Excellence.

M.B.A. - Finance, Investment and Banking: University of Wisconsin–Madison.

B.S. - Chemistry: University of California–Berkeley. During his school at Berkeley, Peter conducted 4 semesters of independent research in bio-inorganic chemistry, and taught introductory Astronomy.
Patents
PATENTS DRAFTED, PROSECUTED, OPINIONS RENDERED

The subject of patent applications drafted, patent applications prosecuted, opinions rendered on, and/or licensing agreements worked on include inventions in synthetic organic chemistry; small-molecular drugs design; pharmaceutics (including CNS actives, oxazolidinone antibiotics, pyrimidine biosynthesis inhibitors, analgesics, ADHD formulations, NMDA antagonists, JAK1 inhibitors, testosterone gels, nasal spray, controlled release formulations, transdermal patch, apparatus for combinatorial synthesis, polymorphism, supercritical fluids, milling apparatus, suspensions and emulsions, paragraph IV certification support); natural product isolation; medical devices (inhalers, stents); biotechnology (sequences, dendritic cell cancer therapy, biochip technology); nanotechnology; thermoset polymers; chromatography; analytical techniques; materials engineering; heterogeneous catalysis; crystallization; ink jets; surfactants; solar cells; reaction design; piezoelectric ceramics; zeolites; algaecides; carbon black; films; and communication devices.
Publications
SELECTED INTELLECTUAL PROPERTY LAW PRESENTATIONS

Invited lecture: Peter D. Mlynek, Recent Changes in the US Patent System Affecting Engineers, IEEE, CoNET, Philadelphia, May 1, 2012.

Invited lecture: Peter D. Mlynek, Introduction to Patent Law and the America Invents Act: An Overview for Non-Lawyers, Chemical Consultants Network, Bala Cynwyd, PA, April, 11, 2012.

Invited lecture: Peter D. Mlynek, Introduction to Patent Law and the America Invents Act: An Overview for Non-Lawyers, ChemPharma Professional Association, Philadelphia, March 6, 2012.

Peter D. Mlynek, Introduction to Patent Law and the America Invents Act: An Overview for Non-Lawyers, ChemPharma Professional Association, Princeton, NJ, February 17, 2012.

Peter D. Mlynek, Laboratory Notebook Keeping Under the Recently Passed America Invents Act Law, Polymer Synergies, LLC, November 16, 2011.

Invited article: Peter D. Mlynek, Who Owns the Intellectual Property Created by Consultants?, Featured Guest Article in The Distillate: Monthly News and Resources for Professionals in the Chemical and BioPharma Industries (An ACS publication), May 2011.

Invited lecture: Peter Mlynek, Consultant Opportunities in Patent Law, Chemical Consultants Network, Bala Cynwyd, PA, February 9, 2011.

Falcon Genomics Awarded Patent for Innovative Cancer Test, BioSpace, May 29, 2009.

Peter D. Mlynek, Patenting Strategies in BRIC Countries for Pharmaceutical Companies, CHAL 33, The 236th National Meeting of the American Chemical Society, Philadelphia, PA, August 20, 2008.
More Publications
ACADEMIC PUBLICATIONS AND PRESENTATIONS

“First-Known High-Nuclearity Copper-Nickel Carbonyl Cluster: [CuxNi35-x(CO)40]5– (with x= 3 or 5) Containing an Unprecedented 35-Atom Three-Layer hcp Triangular Stacking Metal-Core Geometry” Peter D Mlynek, M. Kawano, Michael A. Kozee, Lawrence F. Dahl, J. Cluster Science, 2001, 12 (1), 313-338.

“Recent Advances in High–Nuclearity Monometallic/Bimetallic/Trimetallic Clusters Containing Platinum, Palladium, and/or Nickel in Close-packed or Infinite-chain Metal Cores” L. F. Dahl, M. Kawano, J. W. Bacon, N. T. Tran, J. M. Bemis, M. Kozee, P. D. Mlynek, Oral presentation at the 213th National ACS meeting, Dallas, TX, March 1998.

“New Nickel–Antimony Carbonyl Clusters: Stereochemical Analyses of the [Ni10(SbR)2(CO)18]2– Dianions (R = Me, Et, iPr, tBu, p-FC6H4) Containing Empty 1,12-Ni10Sb2 Icosahedral Cages and of the Unprecedented Stibinido-Bridged 34-Electron Ni2(CO)4(µ2-SbtBu2)2 Dimer” Peter D Mlynek, Lawrence F. Dahl, Organometallics, 1997, 16(8), 1641–1654.

“New Noncentered Icosahedral Nickel-Bismuth Carbonyl Clusters: Geometric Analysis of the Homologous [Ni10(EMe)2(CO)18]2– Dianions (E = P, As, Sb, Bi) Containing Noncentered 1,12-Ni10E2 Icosahedral Cages” Peter D. Mlynek, Lawrence F. Dahl, Organometallics, 1997, 16(8), 1655–1667.

“Synthesis, Isolation, and Characterization of a Variety of High Nuclearity Nickel-Antimony, Nickel-Bismuth, and Nickel-Copper Carbonyl Clusters,” Peter D. Mlynek, Ph.D. thesis, University of Wisconsin–Madison, 1996.

“Revolutionary Advances in Crystallographic Analyses of High-Nuclearity Transition Metal Clusters: From Point-detector to CCD Area Detector Systems” Lawrence F. Dahl, Masaki Kawano, Jeffrey W. Bacon, John M. Bemis, Peter D. Mlynek, Nguyet T. Tran, and Charles F. Campana, 27th International Union of Crystallography Congress, 1996.

“New Nickel–Antimony and Nickel–Bismuth Icosahedral Carbonyl Clusters: Comparative Analysis of the Syntheses, Structures, and Physicochemical / Electrochemical Behavior of the [Ni10(ER)2(CO)18]2– Dianions (E = P, As, Sb, Bi) Containing Non-Centered Icosahedral Ni10E2 Cores" Peter D. Mlynek, Lawrence F. Dahl, Oral presentation at the 208th National ACS meeting, Washington D. C., August 1994, Abstract of Papers, INOR 561.

“The Advantages and Limitations of Statistics” Peter D. Mlynek, J. Chem. Ed. 1991, 68, 180.

“C60 - Buckminsterfullerene: Structural, Synthetic, and Theoretical Studies on a Novel Soccerball-Shaped Molecule" Peter Mlynek, departmental seminar, December 1990.
The ideas, advice and positions expressed by individual members of the Chemical Consultants Network are the member's own and not the responsibility of CCN or its sponsors, the American Chemical Society and the American Institute of Chemical Engineers.

© 2017 Chemical Consultants Network 

Chemical Consultants Nework is jointly supported by AlChE and ACS

Powered by Wild Apricot Membership Software